RENOVORX, INC. Current Liabilities
RENOVORX, INC. (RNXT) had Current Liabilities of $1.88 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $1.88M.
- 2026-03-31: Liabilities, Current $1.92M.
- 2025-12-31: Liabilities, Current $1.96M.
- 2025-09-30: Liabilities, Current $1.88M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $1.88M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.92M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.96M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $1.88M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.56M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.74M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.91M 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.77M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.31M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.09M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $1.18M 10-K · filed 2025-04-01 |
| 2023-09-30 | $1.60M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.70M 10-Q · filed 2023-08-16 |
| 2022-12-31 | $1.10M 10-K · filed 2024-04-01 |
| 2021-12-31 | $938.00K 10-K · filed 2022-03-30 |
| 2021-09-30 | $625.00K 10-Q · filed 2021-11-15 |
| 2020-12-31 | $4.10M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |